Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BNTX

BioNTech SE ADR

107.85

Aug 20 • 9:43 AM ET -5.27 (-4.66%)

Healthcare Biotechnology Germany Large NASD

Aug 19, 7:30 AMModerna/Merck positive mRNA cancer vaccine Phase 3 data lifts BioNTech on sector readthrough

Peers: MRNA ALNY ARGX REGN ONC VRTX BMRN BIIB AMGN GILD

| Held by: FBT IBB FNDF SPDW BBH IDNA BBEU QQQJ IALT BBIN

Scroll to Statements

Index	-
Market Cap	27.09B
Enterprise Value	10.56B
Income	-1.97B
Sales	3.09B
Book/sh	80.82
Cash/sh	67.25
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Jun 02, 2022
Dividend Gr. 3/5Y	- -
Payout	-
Employees	7807
IPO	Oct 10, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	8.76
P/B	1.33
P/C	1.60
P/FCF	56.49
EV/EBITDA	-
EV/Sales	3.41
Quick Ratio	7.80
Current Ratio	7.85
Debt/Eq	0.02
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-7.85
EPS next Y	-6.44
EPS next Q	0.86
EPS this Y	-17.80%
EPS next Y	0.29%
EPS next 5Y	4.46%
EPS past 3/5Y	- -
Sales past 3/5Y	-43.74% 42.57%
EPS Y/Y TTM	-395.95%
Sales Y/Y TTM	-1.05%
EPS Q/Q	-108.42%
Sales Q/Q	-58.46%
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-54.07% -33.16%

Insider Own	0.43%
Insider Trans	-4.42%
Inst Own	19.56%
Inst Trans	-1.30%
ROA	-8.08%
ROE	-9.35%
ROIC	-9.54%
Gross Margin	63.87%
Oper. Margin	-37.57%
Profit Margin	-63.55%
SMA20	14.81%
SMA50	16.48%
SMA200	10.61%
Trades

Shs Outstand	251.20M
Shs Float	250.13M
Short Float	0.99%
Short Ratio	2.31
Short Interest	2.47M
52W High	124.00 -13.02%
52W Low	79.52 35.63%
Volatility	3.57% 3.05%
ATR (14)	4.14
RSI (14)	69.21
Beta	1.31
Rel Volume	7.01
Avg Volume	1.07M
Volume	612,002

Perf Week	17.08%
Perf Month	17.45%
Perf Quarter	19.36%
Perf Half Y	-2.33%
Perf YTD	13.29%
Perf Year	-3.10%
Perf 3Y	-2.27%
Perf 5Y	-68.66%
Perf 10Y	-
Recom	1.67
Target Price	120.40
Prev Close	113.12
Price	107.85
Change %	-4.66%

Date	Action	Analyst	Rating Change	Price Target Change
May-27-26	Upgrade	UBS	Neutral → Buy	$135
May-22-26	Initiated	Bernstein	Mkt Perform	$96
Feb-02-26	Downgrade	Leerink Partners	Outperform → Market Perform	$113
Jan-16-26	Upgrade	Goldman	Neutral → Buy	$142
Jun-05-25	Reiterated	H.C. Wainwright	Buy	$134 → $145
May-29-25	Initiated	Goldman	Neutral	$110
Mar-13-25	Initiated	Citigroup	Buy	$145
Jan-10-25	Initiated	Truist	Buy	$172
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127

Show Previous Ratings

Today 05:30AM	BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026 (GlobeNewswire)
Aug-19-26 03:38PM	Moderna's cancer-vaccine breakthrough drives broad biopharma stock rally (MarketWatch) +21.96%
02:54PM	BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade. (Barrons.com)
08:28AM	Moderna stock is soaring in premarket after encouraging trial of cancer vaccine (MarketWatch)
Aug-04-26 03:01PM	BioNTech SE (BNTX) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress Offsets Revenue ... (GuruFocus.com)
07:12AM	Loading…
07:12AM	Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings (Barrons.com)
06:45AM	BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update (GlobeNewswire)
Aug-03-26 05:00AM	BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer (GlobeNewswire)
Jul-30-26 08:40AM	EU greenlights Pfizer and BioNTech's new COVID vaccine (InvestorsHub)
Jul-29-26 04:30PM	European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union (Business Wire)
Jul-21-26 06:45AM	BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026 (GlobeNewswire)
Jul-07-26 03:22PM	Former Pfizer Building Is Crumbling-Just as the Stock Has (Barrons.com)
Jun-18-26 10:34AM	VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026 (Exec Edge)
May-30-26 02:15PM	Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial (GlobeNewswire)
May-27-26 11:07AM	This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative. (Barrons.com)
05:00AM	Loading…
May-22-26 05:00AM	BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting (GlobeNewswire)
May-20-26 03:29PM	JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms (Investing.com)
May-15-26 04:15PM	BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026 (GlobeNewswire)
May-07-26 06:45AM	BioNTech Announces New ADS Repurchase Program (GlobeNewswire)
May-05-26 09:54AM	BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. (Barrons.com)
07:26AM	BioNTech to Close Sites, Cut Quarter of Workforce in Savings Push (The Wall Street Journal)
06:45AM	BioNTech Announces First Quarter 2026 Financial Results and Corporate Update (GlobeNewswire)
Apr-21-26 06:45AM	BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 (GlobeNewswire) +6.09%
Apr-11-26 07:00AM	BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer (GlobeNewswire)
Mar-24-26 06:45AM	BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer (GlobeNewswire)
Mar-16-26 04:03PM	Covid Vaccine Maker BioNTech Offers Cheap Biotech Play Given Huge Cash Reserves (Barrons.com)
Mar-15-26 05:05PM	Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers (Moneywise)
Mar-11-26 05:55AM	BioNTech price target lowered to $130 from $145 at Citi (TipRanks) +8.28%
Mar-10-26 04:42PM	BioNTech Stock Plunges as Founders Leave. Should You Buy the Dip in BNTX Here? (Barchart) -17.88%
04:20PM	BioNTech Cofounders To Step Down. Stock Crumbles. (Investor's Business Daily)
03:39PM	Loading…
03:39PM	BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls (Benzinga)
03:00PM	BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges (GuruFocus.com)
11:01AM	Kohl's Q4 sales miss, EV maker NIO reports first quarterly profit (Yahoo Finance Video)
10:01AM	BioNTech Tumbles as Founding Duo Plan Leave to Start New Firm (Bloomberg)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
07:40AM	Scientists behind COVID-19 vaccine will depart BioNTech (MarketWatch)
07:18AM	BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. (Barrons.com)
06:50AM	BioNTech Cofounders to Leave to Form New Company (The Wall Street Journal)
06:45AM	BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update (GlobeNewswire)
06:33AM	BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030 (GlobeNewswire)
Mar-09-26 04:17PM	Oracle, Ulta, Adobe, More Stocks With Earnings This Week (Benzinga)
Mar-05-26 12:37PM	Is BioNTech SE (BNTX) A Good Stock To Buy Now? (Insider Monkey)
Mar-04-26 08:14AM	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars (Benzinga)
Feb-25-26 09:00AM	Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 (PR Newswire)
Feb-24-26 06:45AM	BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026 (GlobeNewswire)
Feb-22-26 09:05AM	Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio? (Benzinga)
Feb-20-26 11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
Feb-19-26 03:43AM	BioNTech SE (BNTX) Rallying on Solid Oncology Strategy (Insider Monkey)
Feb-18-26 11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
Feb-09-26 10:29AM	BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
Feb-03-26 11:32AM	Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data (Zacks)
Feb-02-26 09:47AM	Palantir upgraded, Best Buy downgraded: Wall Street's top analyst calls (The Fly)
08:10AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings? (Zacks)
Jan-31-26 06:09AM	Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum (TipRanks)
Jan-30-26 08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
07:58AM	Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings? (Zacks)
02:07AM	Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline (Insider Monkey)
Jan-28-26 09:15AM	Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment (PR Newswire)
09:13AM	BioNTech SE (BNTX): A Bull Case Theory (Insider Monkey)
08:00AM	BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer (GlobeNewswire)
Jan-27-26 01:35PM	2 Biotech Stocks Set to Rebound in 2026 (Motley Fool)
05:38AM	Pfizers CEO on leading after a moonshotand making deals with Trump (Fortune)
05:32AM	What Are Wall Street Analysts' Target Price for Pfizer Stock? (Barchart)
Jan-22-26 10:28AM	BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? (Zacks)
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-20-26 01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
Jan-19-26 09:01AM	What to Expect From Pfizer's Non-Oncology Business in Q4? (Zacks)
Jan-16-26 09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
Jan-14-26 07:59AM	JPM26: BioNTech gears up for multiproduct oncology status by 2030 (Pharmaceutical Technology)
04:04AM	BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan (MarketBeat)
Jan-12-26 06:45AM	BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 09:16AM	BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock? (Zacks)
Dec-23-25 12:53AM	BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. (Insider Monkey)
Dec-18-25 04:45AM	BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field (GlobeNewswire)
Dec-15-25 09:00AM	GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients (NewMediaWire)
Dec-11-25 02:03PM	Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.? (GuruFocus.com)
07:44AM	BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street (Insider Monkey)
Dec-09-25 07:00AM	BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer (GlobeNewswire)
Dec-06-25 03:30PM	BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer (GlobeNewswire)
Dec-03-25 09:01AM	BioNTech Achieves Minimum Condition in CureVac Exchange Offer (GlobeNewswire)
Dec-02-25 09:40AM	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules (Zacks)
Dec-01-25 04:41PM	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 (Investor's Business Daily) -5.58%
03:05PM	FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks (Investopedia)
12:35PM	Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men (MarketWatch)
12:24PM	Nvidia's Synopsys investment, Disney stock pops on Zootopia 2 (Yahoo Finance Video)
12:09PM	Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino (Yahoo Finance Video)
11:05AM	Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals (Barrons.com)
10:09AM	Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths (Investor's Business Daily)
09:59AM	Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals (Barrons.com)
09:36AM	Moderna Falls as FDA Vows to Impose New Vaccine Requirements (Bloomberg)
Nov-26-25 07:30AM	BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration (GlobeNewswire)
Nov-19-25 09:42PM	Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? (Barchart)
Nov-17-25 08:58AM	BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ (Zacks)
Nov-14-25 06:41AM	Pfizer Cuts BioNTech Stake by More Than Half (GuruFocus.com)
Nov-13-25 01:24PM	Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up (GuruFocus.com) -7.00%
06:23AM	CPHI 2025: handprint metric bridges pharma sustainability and economic value (Pharmaceutical Technology)
Nov-05-25 11:41AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-03-25 02:01PM	BioNTech SE (BNTX) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Investments (GuruFocus.com)
07:13AM	BioNTech Boosts FY25 Revenue Outlook - Update (RTT News)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Co-FounderDr. Ugur Sahin M.D.

Co-FounderDr. Ozlem Tureci M.D.

CFO & Member of Management BoardMr. Ramon Zapata-Gomez

MDDr. Sierk Potting Ph.D.

Chief Legal & Business Officer and Member of the Management BoardDr. James Timothy Patrick Ryan Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Medine GmbH	Officer	May 13 '26	Proposed Sale	93.66	858,209	80,379,855		May 12 06:56 PM
Poetting Sierk	Chief Operating Officer	Apr 22 '26	Sale	110.56	50,000	5,527,960	399,387	Apr 23 04:02 PM
Poetting Sierk	Officer	Mar 11 '26	Proposed Sale	83.89	150,000	12,583,500		Mar 11 08:02 AM
Medine GmbH	Officer	Feb 12 '26	Proposed Sale	109.38	858,209	93,870,900		Feb 12 08:17 AM
Tureci Ozlem	Officer	Nov 28 '25	Proposed Sale	102.70	123,331	12,666,094		Nov 28 07:10 AM
Medine GmbH	Officer	Nov 13 '25	Proposed Sale	111.70	1,114,130	124,448,321		Nov 13 08:23 AM
Jeggle Helmut Wolfgang	Director	Nov 05 '25	Proposed Sale	103.43	150,000	15,514,500		Nov 05 04:52 PM
ATHOS KG	10% Owner	Sep 05 '25	Proposed Sale	112.46	500,000	56,230,000		Sep 05 04:41 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your Finviz experience